My research focuses on experimental pathology and molecular toxicology, with particular emphasis on organ toxicity and tumor biology in animal models. I investigate the histopathological and molecular mechanisms underlying drug-induced tissue injury, including chemotherapeutic agents and anti-inflammatory drugs, using immunohistochemical and biochemical approaches.
My work explores key cellular pathways such as apoptosis, oxidative stress, inflammation, ferroptosis, and proliferation markers to better understand tissue damage and therapeutic responses. In addition, I am involved in preclinical tumor models, including glioblastoma and melanoma, aiming to evaluate tumor growth kinetics and the effects of potential anti-tumoral agents.
Overall, my academic interest centers on elucidating molecular signaling pathways in disease models and identifying potential therapeutic targets through translational experimental research.
My research focuses on experimental pathology and molecular toxicology, with particular emphasis on organ toxicity and tumor biology in animal models. I investigate the histopathological and molecular mechanisms underlying drug-induced tissue injury, including chemotherapeutic agents and anti-inflammatory drugs, using immunohistochemical and biochemical approaches.
My work explores key cellular pathways such as apoptosis, oxidative stress, inflammation, ferroptosis, and proliferation markers to better understand tissue damage and therapeutic responses. In addition, I am involved in preclinical tumor models, including glioblastoma and melanoma, aiming to evaluate tumor growth kinetics and the effects of potential anti-tumoral agents.
Overall, my academic interest centers on elucidating molecular signaling pathways in disease models and identifying potential therapeutic targets through translational experimental research.